Kailera Therapeutics Inc (KLRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 111,826 | 160,267 | N/A |
| Marketable Securities | 407,348 | 385,789 | N/A |
| TOTAL | $530,315 | $557,537 | $N/A |
| Non-Current Assets | |||
| PPE Net | 1,854 | 1,955 | N/A |
| Investments And Advances | 76,065 | 118,857 | 0 |
| Other Non-Current Assets | 16,522 | 13,945 | 0 |
| TOTAL | $94,441 | $134,757 | $N/A |
| Total Assets | $624,756 | $692,294 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 7,095 | 7,529 | 0 |
| Accrued Expenses | 46,714 | 37,836 | N/A |
| TOTAL | $54,836 | $46,405 | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 9,644 | 9,983 | 0 |
| TOTAL | $9,644 | $9,983 | $N/A |
| Total Liabilities | $64,480 | $56,388 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 129,566 | N/A | N/A |
| Retained earnings | -447,533 | -368,668 | N/A |
| Other shareholders' equity | 991,832 | 992,593 | 0 |
| TOTAL | $560,276 | $635,906 | $N/A |
| Total Liabilities And Equity | $624,756 | $692,294 | $0 |